Save your place

Sign in to WhoBought

Please try again later.

Cytek Biosciences, Inc. (CTKB) institutional ownership

Latest close $4.58 Jul 20, 2026
Market cap$461M 52-week range SectorHealthcare
Funds holding · Q1 2026
147
reported CTKB position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
85 buyers · 62 sellers

Cytek Biosciences, Inc. (CTKB) price and institutional activity

Dates

Q1 2026

$0 bought by 85 investors
Millennium Management LLCBoston Partners +83 more
$0 sold by 62 investors
Wellington Management Group LLPBrown Capital Management LLC +60 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Cytek Biosciences, Inc. (CTKB) institutional activity · 147

Investor Type Est. change Change Δ Own Date
Millennium Management LLC · Added
Change +1.5M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +1.5M Q1 2026
Boston Partners · Added
Change +794K Date Q1 2026
Boston Partners Added· Q1 2026 +794K Q1 2026
Wellington Management Group LLP · Exited
Change −764K Δ Own −100.0% Date Q1 2026
Wellington Management Group LLP Exited· Q1 2026 −764K −100.0% Q1 2026
Centerbook Partners LP · New
Change +730K Date Q1 2026
Centerbook Partners LP New· Q1 2026 +730K Q1 2026
Brown Capital Management LLC · Reduced
Change −592K Date Q1 2026
Brown Capital Management LLC Reduced· Q1 2026 −592K Q1 2026
Simcoe Capital LLC · Added
Change +584K Date Q1 2026
Simcoe Capital LLC Added· Q1 2026 +584K Q1 2026
Goldman Sachs Group Inc · Added
Change +555K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +555K Q1 2026
Topline Capital Management, LLC · Reduced
Change −378K Date Q1 2026
Topline Capital Management, LLC Reduced· Q1 2026 −378K Q1 2026
Vanguard · Added
Change +368K Date Q1 2026
Vanguard Added· Q1 2026 +368K Q1 2026
Russell Investments Group, Ltd. · Added
Change +359K Date Q1 2026
Russell Investments Group, Ltd. Added· Q1 2026 +359K Q1 2026
Tudor Investment Corp Et Al · New
Change +321K Date Q1 2026
Tudor Investment Corp Et Al New· Q1 2026 +321K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +305K +182.7% Q1 2026
Acadian Asset Management LLC · Reduced
Change −275K Date Q1 2026
Acadian Asset Management LLC Reduced· Q1 2026 −275K Q1 2026
UBS Group AG · Reduced
Change −273K Date Q1 2026
UBS Group AG Reduced· Q1 2026 −273K Q1 2026
AQR Capital Management LLC · Added
Change +169K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +169K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 147

Famous investor activity in Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences, Inc. (CTKB) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Yan Ming · Director Gift (G) -136K
Owned 4.8M Trade date Jun 12, 2026 Filed date Jun 16, 2026
Yan Ming Director Gift (G) -136K 4.8M Jun 12, 2026 Jun 16, 2026
Ball Jack · Director 2 operations 0
Owned 0 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Ball Jack Director 2 operations 0 0 Jun 10, 2026 Jun 12, 2026
Muir Glenn P. · Director 2 operations 85K
Owned 30K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Muir Glenn P. Director 2 operations 85K 30K Jun 10, 2026 Jun 12, 2026
Chin Richard · Director 2 operations 52K
Owned 18K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Chin Richard Director 2 operations 52K 18K Jun 10, 2026 Jun 12, 2026
Imper Vera · Director 2 operations 0
Owned 0 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Imper Vera Director 2 operations 0 0 Jun 10, 2026 Jun 12, 2026
Imper Vera · Director 2 operations 52K
Owned 18K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Imper Vera Director 2 operations 52K 18K Jun 10, 2026 Jun 12, 2026
Neff Deborah J. · Director 2 operations 0
Owned 0 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Neff Deborah J. Director 2 operations 0 0 Jun 10, 2026 Jun 12, 2026
Neff Deborah J. · Director 2 operations 52K
Owned 18K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Neff Deborah J. Director 2 operations 52K 18K Jun 10, 2026 Jun 12, 2026
Holder Michael · Director 2 operations 0
Owned 0 Trade date Jun 10, 2026 Filed date Jun 12, 2026
Holder Michael Director 2 operations 0 0 Jun 10, 2026 Jun 12, 2026
Holder Michael · Director 2 operations 52K
Owned 18K Trade date Jun 10, 2026 Filed date Jun 12, 2026
Holder Michael Director 2 operations 52K 18K Jun 10, 2026 Jun 12, 2026
Holder Michael · Director 2 operations 0
Owned 9K Trade date May 18, 2026 Filed date May 20, 2026
Holder Michael Director 2 operations 0 9K May 18, 2026 May 20, 2026
Chin Richard · Director 2 operations 0
Owned 51K Trade date May 18, 2026 Filed date May 20, 2026
Chin Richard Director 2 operations 0 51K May 18, 2026 May 20, 2026
Yan Ming · Director 8 operations 0
Owned 218K Trade date May 18, 2026 Filed date May 20, 2026
Yan Ming Director 8 operations 0 218K May 18, 2026 May 20, 2026
Yan Ming · Director 4 operations -$20K
Price $3.55 Qty -6K Owned 4.9M Trade date May 18, 2026 Filed date May 20, 2026
Yan Ming Director 4 operations $3.55 -6K -$20K 4.9M May 18, 2026 May 20, 2026
Busque Philippe · Officer 8 operations 0
Owned 128K Trade date May 18, 2026 Filed date May 20, 2026
Busque Philippe Officer 8 operations 0 128K May 18, 2026 May 20, 2026
15 of 58
15 of 58 Sign in to continue to older insider transactions.

Cytek Biosciences, Inc. (CTKB) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 17.8M
% of shares outstanding 13.1% Filing date Jan 23, 2024
BlackRock Inc. 17.8M 13.1% Jan 23, 2024
Vanguard Group Inc 11.9M
% of shares outstanding 8.8% Filing date Feb 13, 2024
Vanguard Group Inc 11.9M 8.8% Feb 13, 2024
Brown Capital Management LLC 9.5M
% of shares outstanding 7.2% Filing date Nov 14, 2024
Brown Capital Management LLC 9.5M 7.2% Nov 14, 2024
Blackrock, Inc. 9.4M
% of shares outstanding 7.2% Filing date Jul 8, 2026
Blackrock, Inc. 9.4M 7.2% Jul 8, 2026
Ra Capital Management, L.P. 9.6M
% of shares outstanding 7.2% Filing date Aug 6, 2021
Ra Capital Management, L.P. 9.6M 7.2% Aug 6, 2021
Millennium Management LLC 7.9M
% of shares outstanding 6.1% Filing date May 18, 2026
Millennium Management LLC 7.9M 6.1% May 18, 2026
Brown Capital Management LLC 7.5M
% of shares outstanding 5.9% Filing date May 15, 2025
Brown Capital Management LLC 7.5M 5.9% May 15, 2025
Ra Capital Management, L.P. 6.8M
% of shares outstanding 5.2% Filing date Feb 22, 2024
Ra Capital Management, L.P. 6.8M 5.2% Feb 22, 2024
8 of 13

Cytek Biosciences, Inc. (CTKB) ownership FAQ

Who owns CTKB?

147 reporting institutions disclosed CTKB position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.